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Ciedflnd, Ohio 
was to study prOtiC 
ronnry perfu ~M~i~~ 
olonged balloon ingatioa has beeu ~ro~se 
improve immediate and long-term results of ~rcut~ueou~ truus- 
luminal coronary angioplasty, but it requires protection agaiust 
A 30.min balloon occlusion of the left anterior 
rtery was ~~orrn~ in three groups of closed chest 
dogs: 1) control (no distal coronary perfusion, n = 
13), 2) passive distal coronary perfusion (autoperfusion cathrlr, 
n = lo), and 3) active distal coronary perfusion (infusion of the 
perihrorocbemical Fluosol at 30 mllmin, n = 11). 
Resufts. At 10 min of balloon inflation, ecbocardiographic wall 
motion indexes (scored from 1 [not-ma!) IO 5 
autoperfusion catheter and FLusol groups (2 
0.9, respectively) uzie significantly better than in the control 
group (3.6 i w.4, p = O.oOl), but at 25 min this improvement in 
%i motion had attenuated and became statistically insignigcu~t 
when compared with values in the control group. Left ventricular 
Prolonged balloon inflation (l-3) may increase the rate of 
immediate angioplasty success (4-6) and provide an alter- 
native treatment for one of the major complications of
coronary angioplasty, acute coronary occlusion (7,8). How- 
ever, it requires myocardial protection against ischemic 
injury. 
Various catheters, perfusates and mechanical devices 
have been employed to provide anterograde or retrograde 
and active or passive distal coronary perfusion during pro- 
longed balloon inflation. The most beneficial results and the 
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evidence of iufur~~i on 
control dogs aud in 
a&z ;f’mosol) distal car 
and better than n 
‘gnificant ~iffe~nce in 
largest experience have been reported with passive 
fusion catheters and with active administration f p 
chemical solutions. Autoperfusion catheters have been 
shown to be effective and safe during prolonged balloon 
inflations in experimental animals (4,9,lQ) and in humans 
(11) and are the most frequently used technique for distal 
coronary perfusion during coronary angioplasty. Reduction 
of intimal hyperplasia n the rabbit model during a 30-min 
balloon inflation with the use of an autoperfusion catheter 
has also been reported (4). Likewise, favorable ffects from 
the infusion of an oxygenated perfluorochemical (Fluosol, 
Alpha Therapeutic) have been observed uring corona: 
balloon occlusions inclosed chest canine models (12-14) an 
in human studies (U-17). Furthermore, distal infusion of 
Fluosol during coronary angioplasty is considered not only 
to ailow longer inflation times but to permit h_ procedure to
be performed more safely in patients who are at high risk or 
in I‘ *stable condition (18,19). 
Tht purpose of this investigation was to use a canine 
model to compare the safety and efficacy of an autoperfusion 
07.51097/92/$5.00 
on occlusion (verifie 
with a coronary a~gio~Ias 
ities and the occurrence of m 
ular arrbyt~lmias or death. 
changes in left ventricular en 
segment. 
ial infarction, ven- 
The research protocol was approved by the &search 
Prqiect and Animal Research Co 
Clinic Foundation. 
were excluded from the study. Anesthesia induction was 
intravenous tbiamylal sodium, 20 mg/kg 
d followed by halothane, 1% by face mask, 
with later titration of halothane dose to depth of anesthesia 
while the animal was mechanically ventilated on room air. 
An arterial blood gas was obtained to docume bysiologic 
values for PI-I, PO, and Pco,. Bilateral groin cutdown 
procedures were performed for insertion of plastic sheaths in
both femoral arteries and one femoral vein. Administration 
of 100 U/kg of heparin was followed by hourly bolus doses of 
20 U/kg. Intravenous lidocaine fvas administered prophyk~- 
tically in all dogs at a bolus dose of 2 mg/ 
g/kg. An 8F pigtail microm 
liar Instruments) was adv 
into the left ventricle. At baseline and every 10 min thereaf- 
ter, heart rate, mear, femoral artery ressure and left ven- 
tricular end-diastolic pressure were 
logic monitor-recorder (IM model, Electronics for 
Medicine). Electrocardiographic (ECG) lead II was moni- 
tored continuously. A baseline two-dimensional echocardio- 
were recorded bo 
given a v/all motion score in blinded ~asbio~ by a single 
observer as foollows: I Tar normal tion, 2 for mild to 
moderate hypokinesia, 3 for severe pokinesia, 4 f63r aki- 
catheter. Arterial blood gas determinations were repeated 
before the start of the prolonged balloon inflation, which was 
delayed in case a 
needed correction. at ecbocard~ography w 
at IO and 25 min 0 alloon in~at~~~. After 
QQ~ was deflated gradually ov 
, the catheters and shea 
down sites sutured. 
yO After 24 h the animal was 
pentobarbital overdose and the heart was excised with a left 
thoracotomy. The left anterior descending, first septal per- 
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Table 1. Hemodynamic and Electrocardiographic Changes During Prolonged Coronary Balloon Inflation With an 
Coronary Perfusion (values are mean -C SD) 
Balloon Inflation 
Test 
GKXp Baseline I lschemia Baseline 2 IO Minutes 20 Minutes 
Control (N = 13) 
HR (beats/min) 
MBP (mm Hg) 
LVEDP (mm Hg) 
ST change (mm) 
APB catheter (n = IO) 
HR (beatslmin) 
MBP (mm Hg) 
LVEDP (mm H@ 
ST change (mm) 
t%osol (n = I I) 
HR (bcatslmin) 
MBP (mm Hg) 
LVEDP (mm Hg) 
ST change (mm) 
112.6 2 17.8 
105.8 lr 13.2 
5.6 * 2.5 
0 
109.0 2 21. I 
107.3 f 18.4 
4.6 -c 2.0 
0 
124.0 + 17.1 
103.9 + 15.9 
4.7 c I.3 
0 
104.6 2 19.1 100.6 it 10.2 
94.4 f 16.4* 92.9 + 15.5t 
8.0 t 4.0* 5.9 LI, 1.9 
I.1 f 1.0* 0.2 c 0.4 
- 
107 9 c 16.0* 
98.3 e 16.lt 
5.7 ?: 2.7 
0.2 + 0.3 
111.5 + 24.3 
104.1 + 8.6 
7.8 r 3.7* 
0.7 tt l.Of 
88.8 + 14.z 
93.7 + 19.2 
5.5 ? I.75 
0.4 2 0.5 
113.5 c 20.2 
95.9 ” 16.3 
10.4 rt 6.31 
0.3 + 0.4 
9Y.2 2 I8.Q 
100.9 + 9.6 
7.6 k 3.9’ 
0.6 + C.7t 
92.6 ? IS.0 
97.1 ? 17.0 
5.9 tt I.9 
0.3 - 0.5 
103.1 + 20.7 
loo.5 + 12.8 
7.6 + 3.6: 
0.7 c I.1 
96.0 t 18.4 
9Y.9 k 17.6 
5.3 It 1.4 
0.5 + 0.7 
112.8 i 20.5 
lO2.8 2 10.2 
19.5 $ S.St.lI 
1.0 1 I.Ot 
*p 5 0.01 versus Bnselinc I. tp 5 0.05 versus Uaseline I. l:p = 0.02 versus Fluosol. $p = 0.05 versus Fluowl. (Jp = O.o(H)~ versus control group and 
autoperfusion catheter, APB = autoperfusion balloon; HR = heart rate; LVEDP = left ventricular end-diastolic pressure: MBP = mean blood pressure. 
forator and left circumflex arteries were cannulated sepa- 
rately with 16gauge cannulas. Differential myocardial per- 
fusion staining was done by direct infusion of 1% 
triphenyltetrazolium chloride into the left anterior descend- 
ing artery acd 0.5% toluidine blue dye into the Arst septal 
perforator and left circumflex arteries. infusions were per- 
formed for 10 min with pressurized bags at 100 mm Hg. This 
staining method allows visual assessment of the left anterior 
descending area at risk for ischemic injury (stained red). area 
of necrosis (not stained) and areas not at risk (staine 
(21,221. The hearts were then placed in 10% buffered formn- 
lin and stored at 4°C for at leust 48 h. Transverse S-~nrn sl’ 
of the let\ ventricle were p~~orrn~d and an observer who 
no knowledge of other data determined the necrotic area (if 
any) snd !hc area st risk for neurosis, as well as the titer 1eft 
ventricular 13rer1, by ~I~Riti~~~ pl~~imetry (Bioquant Syste 
It was assumed that 80% of the ~~ntr~~ 
uevelop ~~~~nifi~aut ~s~berni~ changes (mani- 
fested as myocardial ialfarcti or ventricular a~bythmi~s 
causing death or reqMi~~~ rrent cou~ter~b~k~ 
during or ,after the 
receiving distal coronary 
ischemic changes. OR the 
calculated that it was neces 
blood pressure, :eft ve 
each time *L y were measured during balloon inflation. in 
the autoperfusion catheter and Fluosoi groups, these mea- 
surements were also obtained during and I5 to 20 min afrer 
used to determine which of the three groups 
er exact test was used to test for significant 
ns with the occurrence of complications. 
For each heart slice (9 to 1! se~~e~~ts for each lacart), the 
area at risk for necrosis, the total left ventricular area and the 
ratio of area al risk to left ventricular ratio were calculated 
the sum of the values obtained for each segment. 
rences between groups for these variables were as- 
sessed with use of a Student I test. For all the statistical 
analyses, p values 5 0.05 were considere 
ts of test isc~em~~. There 
were no significant differences among the three study groups 
in hemodynamic, ECG or echocardiographic findings at 
baseline (Table I). One dog initially assigned to receiv: 
passive coronary perfusion had abnormal anteroseptal wail 
on on the baseline echocardiogram and wzs therefore 
drawn from the study and data analysis. As expected, 
test ischemia was associated with significant ST segment 
elevation and increases in left ventricular end-diastolic pres- 
sure in bath the autoperfusion catheter and Fluosol groups, 
as well as with a decreased mean blood pressure. Heart rate 
t change significantly in either group. There were also 
ant wall motion abnormalities during test ischemia in 
both groups (p = 0.001 vs. baseline, Table 2). The number of 
echocardiographic areas at risk was slightly lower in the 
Fluosol group, although the difference was not statistically 
significant (p = 0.07, Table 2). Baseline measurements 
control group. I/p = 0.07 versus otther groups. Abbreviations as in Table I. 
unchanged in the autoperfusi 
I&K end-diastnlic prP+ 
at 10 and 20 min a 
significant ST elevation (p 5 .05) at 20 and 30 mm. 
~cbocardiogra~hic wall motion i 
(indicating fewer ischemic cha 
catheter and Fluosol groups at 1 
control group (Table 2). At pea 
the wall motion index was still lower with both modes of 
distal coronary perfusion, the difference did not achieve 
statistical significance (Table 2). The occurrence of signifi- 
were c~msjdered im rh: final 
control group had evide 
cardial infarction. The 
total left ventricular area for these three dogs was 0.05 in wo 
dogs and 0.02 in the t 
6 3. Complicationb During Prolonged Coronary alloon Occlusion Wit 
Inflation Arrhythmias Repcrfusion Arrhythmias* 
Group Total NSVT VTIVF Lethal Tomi NSVT VTIVF Lethal Ml kilth 
Control (n = 131 6- 2 4 3 4 I 3 0 3 3 
APB catheter (n = 10) 0t 0 0 0 0 0 2 0 0 0 
Fluosol (n = 11) 1$ 0 I 1 2 1 1 1 0 2 
*Of the 10 dogs in each group tha! cocpiered a 30.min inRation. tp = 0.02 versus control. Sp = 0.08 vtrsus - wntrol. APB = autoperfusion b&on: IW = 
myocardial infarction; NSVT = nonsustained ventricular tachycardia: VF = ventricu!ar fibrillation; VT = ventricular tachycardia. 
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The t study. This study shows that passive (auto- 
perfusi atheter) and active (Fluosol infusion) distal cor- 
onary perfusion methods yield comparable and better results 
than those of no perfusion in protecting myocardium against 
ischemia during prolonged coronary balloon occlusions. AS 
u&‘orKiIy seen in experimental and human studies of coro- 
nary balloon occlusion (4,23,243, significant ischemic 
changes were demonstrated by ECG, hemodynamic and 
eehocardiographic data in al1 the control dogs during pro- 
longed inflations. A short balloon inflation was performed in 
the autoperfusion catheter and Fluosol groups to co~~rrn 
that, in ths abscncc of distal coronary perfusion, the dogs 
would have developed ischemic changes at a particular level 
of balloon occlusion. In the dags that later received distal 
coronary perfusion, test ischemia was associated with 
ckanges of similar magnitude to those seen in control ani- 
mails and aided the intcrpretution of the protective e&cts of 
distal coronary perfusion in each group. It has been ~ho~ra 
that a brief cpisodc of ischcmia slows the rate of adenosine 
tt~~~os~batc depletion during subsequent ischemic episodes 
and might actually protect the heart from a subsequent 
sustained ischemic event (25). We do not think that the lack 
of this “preconditioning” (test ischemia) in our control 
group could be ccnsidered a flaw in the study design because 
we used a single period of ischemia of only 30 to 40 s 
duration in contrast to the repetitive episodes of at least 
several minutes of ischemid cmpioyed in preconditioning 
experiments 5). 
The areas a: ris k for ischemia or infarction did not di!l’er 
among groups, ranging from t.84 to 27% of the total left 
ventricular area as determined by echocardrography, and 
averaging 25% to 28% by ~~~tho~~gic plunimetric studies. 
These areas are similar in ma~~i~u~c to those of previous 
exfisr;ments of coronary balloon occlusion in dogs (IO). 
A second set of baseline measurements was obtained in 
the distal coronary perfusion groups after the period of test 
~~chemia and showed slight differences in mean blood pres- 
sure (auto~~us~~~ catheter and Fluosol groups) and heart 
rate (FIuosol group) from values obtained at the first baseline 
study. Considering that the left ventricular end-diastolic 
pressure ruld echocardi~graphic wall motion disturbances 
eJ in the second baseline study and were also seen 
control group, we believe that thess. changes are more 
ction of the usual reaction to anesthesia (early hyper- 
adrenergic state. which resolves as the duration of anesthe- 
sia progresses) than the consequence of residual ischemia. 
During: the early stages of prolonged balloon inflation, 
&tai coronary perfusion was associated with significant 
~duct~~u in ec~~ardiogra~,hic wall motion abnormalities as 
com~~ed with findings in the control group. This difference 
in wvd! m&on seemed to attenuate as the duration of 
ischemia increased, which may be the resu!t of some i;;,- 
PKJvement in wall motion index in control dogs at peak 
inflatio% because the indexes in dogs receiving distal coro- 
nary perfusion did not change with time (Table 
contractility of nonischemic segments may have 
improvement in the overall wall motion 
group at peak balloon inflation. Althou 
was taken during balloon posi 
major branch, ocdusion F r:mall 
may explain, at least in part, why In and other stljdies 
some degree of wall motion ab 
occlusive balloon inflation even w 
sion. Furthermore, the two met 
ventricular end-diastolic pressure and 
were prevented with the use of the ~u?o~c~~s~o 
Seth the control and Fluosol groups h 
in left ve~itricutar end-diastolic 
greater degree in dogs receiving 
gradual incresbe anu me lack of 
Fluusol and zuwperfusion catheter 
namic variables tir echocardiogra 
the increase in left vt,;?ricular 
Fluosol is largely related to the 
of fuid (total 900 ml) into a 
ventricle (most dogs had some degree of hy~oki~esia with 
both methods of distal coronary perfusion, atthougb diastolic 
function was not specifically measured). Pilot experiments 
befc,re this study showed that administration of this amount 
of fluid in the absence of coronary balloon occlusion is 
associated with minor increases i left ventricular end- 
diastolic pressure, which remains in the normal range. 
Another potential explanation for the dispropo~iouate in- 
crease in left ventricular end-diastolic pressure may be a 
diflerential efZect of Fluosol in systolic and diastolic left 
ventricular function during coronary occlusion. Although 
most sttidies have reported amelioration of left ventricular 
systolic dysfunction during coronary angioplasty, they did 
not evaluate diastolic function. A recent randomized, single- 
blind. crossover investigation (26) of 10 patients undergoing 
coronary angioplasty revealed that changes in diastolic func- 
tion variables, including elevation of left ventricular end- 
diastolic pressure, were similar in the Fluosol and control 
groups. The authors (26) concluded that there was a lack of 
preservation of global left ventricular diastolic function by 
Fluosol during coronary balloon occlusion. The ST segment 
elevation observed with Fluosol could have reflected not 
only some degree of myocardial ischemia but a nonischemic 
mechanism as well. Schaer et al. (27) have demonstrated in 
a closed chest canine model that ST segment elevation can 
occur in the presence of well preserved regional myocardial 
contractility during open artery intracoronary infusions of 
Fiuosol. 
Ventricdar ~~r~yt~mias, 
d‘~~iiig the eqwimeiri. All dogs received prophylactic intra- 
venous lidocaine because of the recognized tendency in the 
canine model for the development of ischemia-induced, 
x err anterior descend~flg 
ton catheter, as com- 
averaging 5 13 +: 33 s are safe and reduce ischemic symptoms 
and signs during coronary angioplasty (1I). 
Fluosol has been shown to prevent oz‘ameliorate th  signs 
of myocardiel ischemia due to transient coronary artery 
occlusion. Its beneficial effects have been observed inclosed 
chest dogs during 90- to 120-s occlusive core 
inflations (12,136 and after eperfusion with the 
after a 90-min coronary occlusion (14). In h 
coronary pe 
changes in regional ejection fraction during 45-s balloon 
inflations (15) and can delay the onset of angina nd reduce 
ST segment elevation during inflations lasting 90 s (16). 
There are no previous reports on the continuous use of 
We are grateful to John Frierson. MD, Patrick McGuinn, MD, Trmothy 
ageman, MD, Pedro Andrdde, MD, and Sandeep Dube. 
in the performance of the study, IO kiarlene Goormastic for statistical advice 
and to Rob Lewis. Ron Porter and Ray Terrell for their expert technical 
assistance. 
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